SOUTH SAN FRANCISCO, Calif., April 22, 2026--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to ...
The recent federal action directing the FDA to accelerate the review of psychedelic therapies marks a major shift in the ...
Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced ...
The Speak Foundation today announced the launch of the LGMD Centers of Excellence, a national network of leading academic medical institutions designed to improve coordinated, multidisciplinary care ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the leading SaaS provider of supplier orchestration solutions for the life sciences industry, today announced the launch of its Clinical ...
Advancements in Asthma Treatment: Next Steps and Insights From Clinical Development of Rilzabrutinib
Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, outlines future steps for the clinical development of rilzabrutinib, as well as promising data to advance to phase 3 studies ...
How are you and Formation Bio using AI to accelerate clinical development? We are building many AI tools and systems across the drug development lifecycle to help improve efficiency and outcomes, and ...
Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials.
MELBOURNE, Australia and NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results